Hepatocellular carcinoma classification

Hepatocellular carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes of Hepatocellular carcinoma
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic study of choice
History and symptoms
Physical Examination
Lab Tests
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatocellular carcinoma classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatocellular carcinoma classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatocellular carcinoma classification
CDC on Hepatocellular carcinoma classification
Hepatocellular carcinoma classification in the news
Blogs on Hepatocellular carcinoma classification
Directions to Hospitals Treating Hepatocellular carcinoma
Risk calculators and risk factors for Hepatocellular carcinoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {SH}

Overview

[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].

OR

[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].

OR

Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

OR

If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

OR

The staging of [malignancy name] is based on the [staging system].

OR

There is no established system for the staging of [malignancy name].

Classification

• Hepatocellular carcinoma may be classified according to the histological subtypes:
  • Fibrolamellar carcinoma sarcomatoid HCC
  • Undifferentiated carcinoma
  • Combined HCC-cholangiocarcinoma (HCC-CC)
  • Lymphoepithelioma

Staging

According to the TNM staging system, there are four stages of hepatocellular carcinoma based on the tumor size, lymph node involvement, and distant metastasis.

Primary tumor

TX	Primary tumour cannot be assessed
T0	No evidence of primary tumour
T1	A single tumour with no invasion into the blood vessels of the liver
T2	A single tumour with invasion into the blood vessels or multiple tumours, none more than 5 cm in size
T3a	Multiple tumours, with any tumour larger than 5 cm
T3b	The tumour has grown into either the portal or hepatic vein
T4	The tumour has grown into nearby organs (other than the gallbladder) or the tumour has grown into the layer of tissue that covers the organs in the abdomen (visceral peritoneum)

Regional lymph node

NX	Regional lymph nodes cannot be assessed
NX	No regional lymph node metastasis
NX	Regional lymph node metastasis

Distance metastasis

M0	No distant metastasis
M1	Distant metastasis